- Home
- SCLXW vs GMAB Comparison
SCLXW vs GMAB Comparison
Compare SCLXW & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLXW
- GMAB
- Stock Information
- Founded
- SCLXW N/A
- GMAB 1999
- Country
- SCLXW United States
- GMAB Denmark
- Employees
- SCLXW 115
- GMAB N/A
- Industry
- SCLXW Biotechnology: Pharmaceutical Preparations
- GMAB Biotechnology: Pharmaceutical Preparations
- Sector
- SCLXW Health Care
- GMAB Health Care
- Exchange
- SCLXW Nasdaq
- GMAB Nasdaq
- Market Cap
- SCLXW N/A
- GMAB N/A
- IPO Year
- SCLXW N/A
- GMAB N/A
- Fundamental
- Price
- SCLXW $0.05
- GMAB $20.04
- Analyst Decision
- SCLXW
- GMAB Buy
- Analyst Count
- SCLXW 0
- GMAB 9
- Target Price
- SCLXW N/A
- GMAB $39.17
- AVG Volume (30 Days)
- SCLXW 4.0K
- GMAB 1.6M
- Earning Date
- SCLXW 03-07-2025
- GMAB 05-08-2025
- Dividend Yield
- SCLXW N/A
- GMAB N/A
- EPS Growth
- SCLXW N/A
- GMAB 83.82
- EPS
- SCLXW N/A
- GMAB 16.85
- Revenue
- SCLXW $55,152,000.00
- GMAB $2,988,286,182.00
- Revenue This Year
- SCLXW N/A
- GMAB $19.81
- Revenue Next Year
- SCLXW N/A
- GMAB $13.94
- P/E Ratio
- SCLXW N/A
- GMAB $11.44
- Revenue Growth
- SCLXW 22.02
- GMAB 30.67
- 52 Week Low
- SCLXW $0.18
- GMAB $17.24
- 52 Week High
- SCLXW $0.18
- GMAB $30.41
- Technical
- Relative Strength Index (RSI)
- SCLXW N/A
- GMAB 53.71
- Support Level
- SCLXW N/A
- GMAB $17.24
- Resistance Level
- SCLXW N/A
- GMAB $18.97
- Average True Range (ATR)
- SCLXW 0.00
- GMAB 0.65
- MACD
- SCLXW 0.00
- GMAB 0.21
- Stochastic Oscillator
- SCLXW 0.00
- GMAB 95.90
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.